Category for posts not assigned a category.
ECS Botanics (ECS) has secured a $9.9 million supply agreement for medicinal cannabis products in Germany. The company entered a binding agreement with German company Ilios Santé GmbH for the supply of medicinal cannabis. Under the contract, ECS will exclusively supply four medicinal cannabis strains to Ilios Sante, with the first supply anticipated once product…
ECS Botanics Holdings Ltd (ASX:ECS) managing director Nan-Maree Schoerie brings Proactive’s Elisha Newell up to speed on the company’s value proposition ahead of the Peak Asset Management Microcap Conference on Thursday, July 13
ECS Botanics (ECS) has entered two offtake agreements worth a combined more than $11.9 million to supply medicinal cannabis dried flower in Australia. The company announced it will supply Melbourne-based Entoura with Good Manufacturing Practice (GMP) medicinal cannabis dried flower, worth $10.2 million over three years. Entoura supplies and develops high-quality medicinal cannabis products, but also…
Medicinal cannabis company, ECS Botanics (ECS) has launched the sale of two assets and secured a new loan facility. The company agreed to sell its hemp food and wellness business for $250,000 to Ananda Food, with contract completion expected in August upon the finalisation of due diligence. In addition, the company has planned to sell its…
ECS Botanics (ECS) has reached financial settlement of its Tasmanian medicinal cannabis business and assets for $3 million. The medicinal cannabis company agreed to sell its subsidiary, TasCo, which holds its Tasmanian operations and farm, to Blue Buffalo for $3 million. On October 24, the company announced to the market it had entered an unconditional…
Shares in ECS Botanics (ASX: ECS) rose by more than 22 per cent this morning after the Victorian medicinal cannabis grower and manufacturer announced its third supply contract win in just over three months, taking the total value of agreements reached since late June to $35.9 million.
ECS Botanics Ltd (ASX:ECS) managing director Nan-Maree Schoerie tells Proactive the company is an Australian medicinal cannabis cultivator and manufacturer with operations in northwest Victoria.
ECS Botanics (ECS) has reported significant growth in its December quarter, achieving its key milestone of positive quarterly cashflow.
Australian Cannabis Companies 2022 – top 20 list Whether it’s a “gold rush” to secure registration for selling over-the-counter at chemists, proactive outreach to get clinicians on side, or pocket-emptying, long-game research requiring patience and patients at a pharmaceutical level, medicinal cannabis is an industry that attracts all stripes. Against the backdrop of a global…
The House of Representatives passed a bill on Friday that would decriminalize marijuana, fueling hopes that the U.S. was one step closer to opening its doors to the cannabis industry at the federal level. The news invigorated cannabis stocks last week, but experts cautioned that marijuana bulls should tamp down their expectations that the measure, called the…
Aussie medicinal cannabis and hemp company group ECS Botanics has recorded a massive jump in revenue amid growing global demand for its unique set of products, here’s to you ECS investors. ECS Botanics (ASX:ECS) has been justly climbing the ASX on Wednesday after the outward looking Aussie cannabis play revealed an impressive 312% increase in first…
In this podcast with Alex Keach, Managing Director of ECS Botanics, we chat about: Growing cannabis in Australia Domestic vs. International cannabis Import vs exports B2B cannabis The ideal candidate to work on a cannabis farm Produced by: AltMed
The Therapeutic Goods Administration (TGA) Australia has released details of the much-anticipated changes to medicinal cannabis quality, packaging and labelling requirements which will go into effect on July 1, 2023. Cannabiz exclusively revealed the TGA was considering reforming import quality standards in October 2020. Throughout the consultation period, issues were raised around an uneven playing field, where locally made medicinal…
Cannabis in Australia – It was late 2020 when David decided to talk to his GP about getting a prescription for medicinal cannabis. He’d been diagnosed with fibromyalgia — a condition characterised by widespread pain and tenderness in the body — and had been mostly self-medicating with cannabis he’d bought illegally. “Fibromyalgia is quite debilitating,” he said….
Growing demand is boosting revenue for medicinal cannabis and hemp company ECS Botanics, which is on track for a massive revenue increase this quarter and a bumper outdoor harvest. Shares in ECS Botanics (ASX:ECS) rose ~4% to 0.026 cents today on news the company was on track to deliver $2 million in revenue for Q3 FY22. Driven…
Medicinal cannabis and hemp company ECS Botanics Holdings(ASX: ECS) has announced it is on track to deliver another consecutive quarter of revenue growth thanks to sales of its dried flower and cannabis oil products. The company expects to report revenue of about $2 million for the quarter due to end 31 March, which would represent a 39%…
Hemp businesses in the US are suffering from Facebook and Instagram’s strict advertising rules despite the product — and its cultivation — being legal in the country for a number of years. Entrepreneur Mike Goose, whose company Let There Be Hemp makes tortilla chips from hemp seeds, has had ads rejected by Facebook since 2019…
The company’s latest quarterly update confirmed its standing as a market leader in Australia’s medicinal cannabis sector. Leading medicinal cannabis and hemp supplier ASX ECS Botanics (ASX:ECS) went from strength to strength in 2021, building out a strong pipeline of domestic and international clients as it scales up to meet demand. And that growth was confirmed with…
If you’ve been a student of the fertile cannabis space, this morning’s latest revenue surge is textbook ECS Botanics Holdings Ltd. Underpinned by sensible management, consistently reliable execution and a unique B2B business model, the premium medicinal cannabis and hemp supplier ECS Botanics (ASX:ECS) continues to step it up, following another strong revenue update this morning. The company…
ECS Botanics has had another incredibly productive quarter, producing revenue of over $2m in Q3. And with the European majors opening up, the vertically integrated company says it’s in a great position with harvesting currently underway. Benchmark Aussie medicinal cannabis play ECS Botanics (ASX:ECS) has delivered more than $2million in revenue for the third quarter, as demand…
